OPEN CFDA 93.242 ↗ Competitive Grant Hard ~100h to apply

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

🏛 National Institutes of Health (HHS-NIH11)

⏰ Deadline
Sep 7, 2026 in 86 days
📍 Scope
International

Can you apply?

This grant is for researchers and research-focused organizations seeking NIH funding to investigate social disconnection and suicide risk in older adults. Eligible applicants typically include institutions with NIH research infrastructure (universities, medical centers, research hospitals), principal investigators holding doctoral degrees (Ph.D., M.D., D.O., or equivalent), and organizations with established research administration capabilities. The R21 mechanism supports exploratory/developmental research with flexible timelines and budget limits. Both domestic and international institutions can apply, though domestic ones are prioritized. Research must focus on understanding mechanisms linking social disconnection to suicide risk in late life, with clinical trial components optional. Applicants must have institutional oversight boards (IRB) and, if human subjects are involved, demonstrate appropriate protections and compliance infrastructure.

Eligible applicants
Check your eligibility — what type of organization are you?

Program description

This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide.

Who can apply

Eligible applicants

Demographic focus

How to apply

Application links

Required documents

  • SF-424 (R&R) form (NIH standard application form)
  • Project Narrative (research plan), typically 6 pages
  • Specific Aims (1 page)
  • Background and Significance
  • Preliminary Studies/Progress Report
  • Research Design and Methods
  • Budget and Budget Justification (NIH R&R Budget Form)
  • Biographical Sketches of key personnel (Form Page 2, limit typically 2 pages per person)
  • Facilities and Other Resources documentation
  • Letters of Support from collaborating institutions or recruitment partners
  • IRB approval letter or statement of human subjects involvement (if applicable)
  • Data Safety Monitoring Plan (if clinical trial included)

Program contact

Funding track record

Recent awards under CFDA 93.242 from the last 3 years — real organizations that won funding through this same program.

57
awards (3 yrs)
$1.5B
total funded
37
unique recipients
$27.0M
average award

Top 10 Largest Recent Awards

  1. $75,056,208
  2. $74,756,329
  3. $72,845,834
  4. $64,705,159
  5. $63,991,707
  6. $54,214,022
  7. $38,895,082
  8. $38,475,557
  9. $34,635,977
  10. $34,475,710

Top States by Funding

  • CA 15 awards $408.1M
  • MA 9 awards $230.4M
  • NY 6 awards $184.2M
  • WA 4 awards $174.9M
  • CT 3 awards $138.9M

Source: USAspending.gov — federal spending transparency. Data covers last 3 years.

Funding history

Annual funding for this program — Federal obligations (CFDA 93.242). How funding has trended year over year.

2024 $1,722,300,004
2025 $1,726,864,191
2026 est. $99,221,272

FAQ

Who can serve as Principal Investigator for an R21?

Typically a researcher with a doctoral degree (Ph.D., M.D., D.O., or equivalent) and prior research experience. Early-career researchers are encouraged; a strong track record is less critical than feasibility of the proposed project.

What is the typical funding range for R21s?

R21 grants commonly range from $150,000 to $300,000 total costs over 2 years, though this varies by NIH institute. Check your specific IC's guidelines; some allow higher budgets for clinical trials.

Can my team include clinicians even if we're not doing a clinical trial?

Yes. This R21 explicitly notes clinical trial is optional, so observational research, mechanistic studies, and cross-sectional work all qualify. Clinicians strengthen proposals examining suicide risk.

What makes an R21 application competitive?

Clear articulation of the gap your research fills; preliminary data showing feasibility; a realistic scope (R21s are smaller/faster than R01s); experienced research team; and strong institutional support for participant recruitment and retention in geriatric populations.

When should I submit, and are there multiple deadlines?

The fixed deadline is September 7, 2026. NIH typically has 2-3 submission windows per year for R21s; check NIH's funding calendar for earlier deadlines if you want to apply sooner.

💡 Tips for applicants

  • Build in partnerships with geriatric clinics, senior centers, or community organizations experienced recruiting older adults; reviewers value real recruitment pathways, not just assumptions.
  • Highlight preliminary data on social disconnection or suicide risk in your population. Even pilot data from chart reviews or small feasibility studies strengthens R21 applications significantly.
  • Frame your research question tightly: R21s expect a narrower, more focused scope than R01s. Avoid trying to answer too many sub-questions; demonstrate you can achieve your specific aims in the 2-year window.
  • Address recruitment and retention head-on. Suicide risk research in older adults faces unique ethical and logistical challenges; show you've thought through informed consent, safety protocols, and follow-up procedures.
  • Check the specific NIH Institute or Center (IC) funding guidelines. Suicide risk and aging research may be reviewed by multiple ICs (National Institute on Aging, NIMH, NCCIH); confirm which IC administers your proposal and read their current priorities and review criteria.

⚠️ Common mistakes

R21 applications often fail because researchers overreach the exploratory scope—attempting interventions or sample sizes too ambitious for a 2-year, limited-budget mechanism. Another frequent error is weak preliminary data; reviewers expect at least some evidence of feasibility, not just promising ideas. Finally, applications that underestimate the complexity of recruiting and retaining suicidal or high-risk older adults, without concrete partnerships or proven recruitment strategies, rarely succeed.

Similar grants

86 days left Sep 7, 2026
Apply →